EP Patent
EP3765138A1 — Ingestible device with relatively large payload volume
Assigned to Biora Therapeutics Inc · Expires 2021-01-20 · 5y expired
What this patent protects
Ingestible devices with a relatively large payload volume or sample volume, as well as related components, systems and methods, are disclosed.
USPTO Abstract
Ingestible devices with a relatively large payload volume or sample volume, as well as related components, systems and methods, are disclosed.
Drugs covered by this patent
- Abilify (aripiprazole) · Generic (originally Otsuka/BMS)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.